Medication info
Weltrasemi Tablet

Weltrasemi Tablet

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›18.75mg / 1 tabletAcetaminophen›162.5mg / 1 tablet
Manufacturer / importer
Aprogen Biologics Co., Ltd.
Appearance
Pale yellow oblong film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201502713 · Approved 2015.04.30 · Insurance code 645208780

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, doses should be taken at intervals of at least 6 hours, and the total dose should not exceed 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not administer this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, regular monitoring should be performed to determine whether treatment with this medicine should be continued. Elderly patients Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to elderly patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly during hemodialysis and hemofiltration, readministration of this medicine after dialysis is not necessary to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, doses should be taken at intervals of at least 6 hours, and the total dose should not exceed 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not administer this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, regular monitoring should be performed to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
Aprogen Biologics Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, doses should be taken at intervals of at least 6 hours, and the total dose should not exceed 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not administer this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, regular monitoring should be performed to determine whether treatment with this medicine should be continued. Elderly patients Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to elderly patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly during hemodialysis and hemofiltration, readministration of this medicine after dialysis is not necessary to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, doses should be taken at intervals of at least 6 hours, and the total dose should not exceed 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not administer this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, regular monitoring should be performed to determine whether treatment with this medicine should be continued.

Precautions

This medication may cause liver damage, so individuals who regularly consume three or more alcoholic beverages daily should consult with a doctor or pharmacist before taking it. If skin rashes or hypersensitivity reactions occur while taking this medication, discontinue use immediately and inform medical personnel. Care should be taken with patients who have a history of seizures or factors that increase the risk of seizures. Rarely, serious allergic reactions may occur; if symptoms such as difficulty breathing or hives arise, immediate medical attention is necessary. Patients with severe asthma or respiratory issues should use this medication in a monitored environment due to the risk of respiratory depression. Caution is advised when used in combination with alcohol or central nervous system depressants, as severe drowsiness or respiratory depression may occur. Patients with head injuries or increased intracranial pressure should be careful when using this medication, as symptoms may worsen. This medication may cause psychological and physical dependence, so careful monitoring for dependence should be conducted with long-term use. Patients with impaired liver or kidney function, especially those with liver dysfunction, must consult with a specialist before taking this medication. This medication should not be used in children under 12 years old or in adolescents under 18 who have undergone tonsillectomy or adenoidectomy. This medication may cause obstructive sleep apnea or hypoxemia; periodic checks for these symptoms should be conducted. Due to the risk of hyponatremia, patients who are elderly or have risk factors for hyponatremia should be monitored through blood tests. Drowsiness or dizziness may occur during treatment, so caution should be exercised when driving or operating machinery. In case of overdose, severe respiratory depression, seizures, liver damage, etc., may occur; therefore, it is crucial to adhere to the prescribed dosage and contact a medical institution immediately in case of overdose. Pregnant or breastfeeding women should consult a doctor before taking this medication, and breastfeeding mothers should refrain from use for safety reasons. This medication may interact with other drugs, so if currently using other medications, it is essential to inform medical personnel and exercise caution.

Side effects

Liver damage, acute general pustular exanthema, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, death, hyponatremia, decreased appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, irritability, emotional instability, euphoria, decreased libido, sleep disorders, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory impairment, tremor, paresthesia, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, visual disturbances, visual impairment, miosis, vertigo, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweat, urinary disorders, erectile dysfunction, asthenia, chest pain, emotional abnormality, chills, thoracic discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, hot flushes, weight loss, increased serum creatinine, anaphylactic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, influence on emotional instability, delirium, suicidal ideation, hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, hypoprothrombinemia, hyperglutamic acidosis, high anion gap metabolic acidosis, fixed rash, asthenia, fever, edema, rigidity, syncope, congestive heart failure, dizziness, confusion, exacerbation of migraine, involuntary muscle contractions, exertional dyspnea, cough, bronchitis, urinary retention, increased frequency of urination, abnormal renal function, oliguria, rash, increased sweating, urticaria, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, decreased appetite, anxiety, depression, irritability, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, decreased platelets, palpitations, arrhythmia, exacerbation of hypertension, aortic stenosis, gastrointestinal bleeding, increased cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, liver dysfunction, nausea, dizziness, dyspnea, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, vomiting, dyspepsia, confusion, multiple organ failure, anaphylaxis, deliberate overdose, belching, chest discomfort, anxiety, sweating, rigidity, pain, upper respiratory syndrome, lip smacking, agitation, hyperactivity, panic attacks, severe anxiety, tinnitus, abnormal central nervous system response, urticaria, bronchospasm, toxic skin necrosis, allergic reactions, withdrawal symptoms, symptoms of acute or chronic adrenal insufficiency, opioid-induced hyperalgesia, respiratory arrest, QT prolongation, somnolence, heart attack

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, and it is recommended to keep it at a cool temperature below 25 degrees Celsius. Proper storage will maintain the effectiveness of the medication longer.

Appearance and packaging

Appearance

Pale yellow oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.